Effect of nursing-led auricular acupressure on chemotherapy-induced peripheral neuropathy of patients with breast cancer
-
摘要:目的
观察护理主导的耳穴压豆疗法在改善紫杉醇类药物化疗乳腺癌患者周围神经病变症状中的效果。
方法将86例患者随机分为研究组和对照组，每组43例。研究组采用传统西医治疗结合耳穴压豆法进行干预，对照组采用传统西医治疗。比较2组患者临床疗效及周围神经病变症状评分。
结果治疗后, 2组患者肢体麻木、肢体疼痛、倦怠乏力和腱反射评分均低于治疗前，且研究组患者上述评分低于对照组，差异均有统计学意义(P < 0.05)。研究组患者总有效率为88.4%(38/43), 高于对照组的74.4%(32/43), 差异有统计学意义(P < 0.05)。
结论护理主导的耳穴压豆疗法联合甲钴胺可改善接受紫杉醇类药物治疗的乳腺癌患者周围神经毒性症状，具有无创简单、安全灵活、经济实用、依从性好等优势。
Abstract:ObjectiveTo observe the effect of nursing-led auricular acupressure therapy in improving the symptoms of peripheral neuropathy in breast cancer patients with chemotherapy of paclitaxel.
MethodsA total of 86 patients were randomly divided into study group and control group, with 43 cases in each group. The study group was treated with traditional western medicine and auricular acupressure, while the control group was treated with traditional western medicine alone. The clinical efficacy and scores of peripheral neuropathy symptoms were compared between the two groups.
ResultsAfter treatment, the scores of limb numbness, limb pain, fatigue and tendon reflex in both groups were significantly lower than those before treatment, and the scores of the above symptoms in the study group were significantly lower than those in the control group (P < 0.05).The total effective rate of the study group was 88.4% (38/43), which was significantly higher than 74.4% (32/43) in the control group (P < 0.05).
ConclusionThe nursing-led auricular acupressure therapy combined with mecobalamin can improve the symptoms of peripheral neurotoxicity in breast cancer patients treated with paclitaxel, with the advantages of non-invasiveness, simplicity, safety, flexibility, cost-effectiveness, and good compliance.
-
Keywords:
- nursing /
- auricular acupressure therapy /
- breast cancer /
- chemotherapy /
- peripheral neuropathy /
- paclitaxel
-
-
表 1 2组患者一般资料比较[n(%)]
变量 分类 对照组(n=43) 研究组(n=43) χ2 P 年龄 ≤40岁 7(16.3) 8(18.6) 0.081 0.760 >40岁 36(83.7) 35(81.4) 绝经情况 未绝经 22(51.2) 19(44.2) 0.420 0.517 已绝经 21(48.8) 24(55.8) 分期 Ⅱ期 32(74.4) 34(79.1) 0.261 0.610 Ⅲ期 11(25.6) 9(20.9) 病理类型 浸润性导管癌 38(88.4) 40(93.0) 0.551 0.458 浸润性小叶癌 5(11.6) 3(7.0) 紫杉醇类药物 紫杉醇 35(81.4) 38(88.4) 0.816 0.366 白蛋白结合型紫杉醇 8(18.6) 5(11.6) 蒽环类药物 表柔比星(法玛新) 15(34.9) 18(41.9) 0.443 0.506 表柔比星(艾达生) 28(65.1) 25(58.1) 
下载: 导出CSV
表 2 2组患者治疗前后周围神经病变症状评分比较(x±s)
分 周围神经病变症状 时点 对照组(n=43) 研究组(n=43) 肢体麻木 治疗前 2.02±0.67 1.95±0.79 治疗后 1.42±0.55* 0.98±0.83*# 肢体刺痛 治疗前 1.93±0.77 2.00±0.79 治疗后 1.56±0.59* 1.09±0.48*# 疲倦乏力 治疗前 1.91±0.68 1.88±0.82 治疗后 1.67±0.72* 1.14±0.47*# 腱反射 治疗前 1.88±0.69 1.86±0.97 治疗后 1.77±0.61* 1.40±0.82*# 与治疗前比较, * P < 0.05; 与对照组比较, #P < 0.05。
下载: 导出CSV
表 3 2组患者治疗后临床治疗效果比较[n(%)]
组别 n 显效 有效 无效 总有效 对照组 43 10(23.3) 22(51.1) 11(25.6) 32(74.4) 研究组 43 22(51.2) 16(37.2) 5(11.6) 38(88.4)* 与对照组比较, * P < 0.05。
下载: 导出CSV
-
[1] SERETNY M, CURRIE G L, SENA E S, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis[J]. Pain, 2014, 155(12): 2461-2470.
[2] Sugimoto M, Komatsu H, Hayashida T. Association of chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among breast cancer patients[J]. Journal of Japanese Society of Cancer Nursing, 2021, 35: 29-35.
[3] DEMIRCI U. Management of patients with factor Ⅶ deficiency in surgery: a single center experience[J]. Erciyes Med J, 2021, 44(2): 222-228.
[4] FRADKIN M, BATASH R, ELMALEH S, et al. Management of peripheral neuropathy induced by chemotherapy[J]. Curr Med Chem, 2019, 26(25): 4698-4708.
[5] SELVY M, PEREIRA B, KERCKHOVE N, et al. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices[J]. Support Care Cancer, 2021, 29(7): 4033-4043.
[6] SAMUELS N, BEN-ARYE E. Integrative approaches to chemotherapy-induced peripheral neuropathy[J]. Curr Oncol Rep, 2020, 22(3): 23.
[7] SCHUTZMEIER P, KUTZORA S, MITTERMEIER I, et al. Non-pharmacological interventions for pollen-induced allergic symptoms: Systematic literature review[J]. Pediatr Allergy Immunol, 2022, 33(1): e13690. http://pubmed.ncbi.nlm.nih.gov/34717016/
[8] KIEFFER J M, POSTMA T J, VAN DE POLL-FRANSE L, et al. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)[J]. Qual Life Res, 2017, 26(11): 2999-3010.
[9] BÉRUBÉ-MERCIER P, TAPP D, CIMON M ō, et al. Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol[J]. BMJ Open, 2022, 12(4): e057950.
[10] ARGYRIOU A A, KOLTZENBURG M, POLYCHRONOPOULOS P, et al. Peripheral nerve damage associated with administration of taxanes in patients with cancer[J]. Crit Rev Oncol Hematol, 2008, 66(3): 218-228.
[11] 徐革, 连娜琪, 于洋, 等. 化疗药所致周围神经病变发生机制和治疗的研究进展[J]. 医学综述, 2020, 26(18): 3601-3605, 3611. doi: 10.3969/j.issn.1006-2084.2020.18.012 [12] TAWFIK A A, HAMZA S A, ADLY N N, et al. Pattern of cognitive impairment among community-dwelling elderly in Egypt and its relation to socioeconomic status[J]. J Egypt Public Health Assoc, 2024, 99(1): 4.
[13] YEH C H, LUKKAHATAI N, CAMPBELL C, et al. Preliminary effectiveness of auricular point acupressure on chemotherapy-induced neuropathy: part 1 self-reported outcomes[J]. Pain Manag Nurs, 2019, 20(6): 614-622.
[14] Mai Q, Li X, Yang D, et al. Effects of acupressure on cancer-related pain management: a systematic review and meta-analysis of randomized controlled trials[J]. Eur J Integr Med, 2022, 51: 102120.
[15] 王小玲, 钱巧云, 徐丽霞. 耳穴埋籽配合心理护理对乳腺癌化疗致恶心及呕吐的干预[J]. 实用临床医药杂志, 2017, (12): 177-178. doi: 10.7619/jcmp.201712058 [16] LI T, PARK S B, BATTAGLINI E, et al. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use[J]. Qual Life Res, 2022, 31(11): 3091-3107.
[17] 武琼华, 孙淑琴, 王静, 等. 中药穴位贴敷外治法干预糖尿病周围神经病变的临床疗效[J]. 实用临床医药杂志, 2023, 27(20): 137-141. doi: 10.7619/jcmp.20231985 [18] 周肖, 丁彩艳, 刘慧, 等. 化疗致外周神经毒性患者适应性研究进展[J]. 实用临床医药杂志, 2022, 26(8): 137-142, 148. doi: 10.7619/jcmp.20214940 -
期刊类型引用(16)
1. 李丹. 辛伐他汀联合阿司匹林治疗对缺血性脑血管病患者的影响. 黑龙江医药科学. 2022(01): 124-125 . 
百度学术
2. 吴灿珍. 辛伐他汀结合阿司匹林防治缺血性脑血管病的临床疗效观察. 北方药学. 2022(02): 65-67 . 百度学术
3. 刘宇. 神经介入溶栓术对缺血性脑血管病患者血管内皮功能及血流动力学的影响探讨. 中国现代药物应用. 2022(21): 39-42 . 百度学术
4. 谭川. 辛伐他汀联合阿司匹林防治缺血性脑血管病的效果及药学分析. 北方药学. 2022(09): 19-21+25 . 百度学术
5. 王浩，胡春梅. 辛伐他汀联合阿司匹林对缺血性脑血管病的防治作用. 中国实用医药. 2021(21): 93-95 . 百度学术
6. 杨进平，袁磊，闻瑛，王敏玲. 五虫通络汤辅助阿司匹林对急性缺血性脑血管病患者神经功能及MBP、H-FABP血清表达的影响. 中国中医急症. 2021(07): 1278-1281 . 百度学术
7. 姜文彬，陈敬阳，杨舒越，张帆. 血小板聚集功能检测在缺血性脑血管病防治中的临床应用. 中国实用医药. 2020(03): 33-35 . 百度学术
8. 王晓芳. 他汀类与抗血小板聚集药物联用对缺血性脑血管病治疗的效果. 血栓与止血学. 2020(02): 203-205 . 百度学术
9. 阎保伟. 银杏叶片联合辛伐他汀治疗颈动脉粥样硬化的临床疗效观察. 中国医药导刊. 2019(02): 86-89 . 百度学术
10. 赵婷婷. 心脑血管疾病患者口服阿司匹林依从性影响因素及预防分析. 中国处方药. 2019(04): 49-50 . 百度学术
11. 沈丽丽. 辛伐他汀联合阿司匹林治疗缺血性脑血管病的疗效及复发率分析. 中国实用医药. 2019(11): 78-79 . 百度学术
12. 王新强，李海霞，王高临，李斌，陈静. 不同剂量阿托伐他汀钙片治疗缺血性脑血管病的疗效对比分析. 世界最新医学信息文摘. 2019(69): 142+144 . 百度学术
13. 康惠芬. 辛伐他汀治疗心脑血管疾病的临床疗效分析. 系统医学. 2019(21): 85-87 . 百度学术
14. 李伦. 阿司匹林联合阿托伐他汀防治缺血性脑血管病临床探讨. 中西医结合心血管病电子杂志. 2019(34): 56 . 百度学术
15. 张建平. 辛伐他汀联合阿司匹林治疗缺血性脑血管病的疗效及复发率分析. 心血管外科杂志(电子版). 2018(01): 3-4 . 百度学术
16. 王俊岗. 辛伐他汀+阿司匹林治疗脑血栓的临床疗效观察及有效性分析. 家庭医药.就医选药. 2019(01): 192-193 . 百度学术
其他类型引用(1)
计量
- 文章访问数: 125
- HTML全文浏览量: 18
- PDF下载量: 6
- 被引次数: 17
苏公网安备 32100302010246号
